We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare Diseases

News   Mar 16, 2018 | Original story from Louisiana State University

 
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare Diseases

Chemotherapeutic vandetanib bound to its main target, Protein Tyrosine Kinase 6, or PTK6, in purple, which is involved in many cancers including gastrointestinal tumors and ovarian cancers. By modeling vandetanib and PTK6 complex, researchers at LSU found the KRAS protein to also contain a similar drug-binding site and therefore to be a good match for the same drug. The computer-generated model of KRAS in gold with vandetanib depicts the predicted interaction. Credit: Misagh Naderi, LSU

 
 
Advertisement
 

RELATED ARTICLES

Artificial Genes Sense Cellular Responses to Drugs

News

BUSM researchers have developed and implemented a new way to better understand how human cells communicate with each other, how this communication is disrupted in human diseases and how this can be corrected pharmacologically.

READ MORE

Modified Form of Vitamin K Shows Promise Against Drug-resistant Epilepsy

News

A team of researchers has reported that a new vitamin K-based drug has proved effective in mouse models of medication-resistant seizures.

READ MORE

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE